These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20652950)

  • 21. Heterozygous mutations in cyclic AMP phosphodiesterase-4D (PDE4D) and protein kinase A (PKA) provide new insights into the molecular pathology of acrodysostosis.
    Kaname T; Ki CS; Niikawa N; Baillie GS; Day JP; Yamamura K; Ohta T; Nishimura G; Mastuura N; Kim OH; Sohn YB; Kim HW; Cho SY; Ko AR; Lee JY; Kim HW; Ryu SH; Rhee H; Yang KS; Joo K; Lee J; Kim CH; Cho KH; Kim D; Yanagi K; Naritomi K; Yoshiura K; Kondoh T; Nii E; Tonoki H; Houslay MD; Jin DK
    Cell Signal; 2014 Nov; 26(11):2446-59. PubMed ID: 25064455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In cardiac myocytes, cAMP elevation triggers the down-regulation of transcripts and promoter activity for cyclic AMP phosphodiesterase-4A10 (PDE4A10).
    McCahill A; Campbell L; McSorley T; Sood A; Lynch MJ; Li X; Yan C; Baillie GS; Houslay MD
    Cell Signal; 2008 Nov; 20(11):2071-83. PubMed ID: 18721873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells.
    Growcott EJ; Spink KG; Ren X; Afzal S; Banner KH; Wharton J
    Respir Res; 2006 Jan; 7(1):9. PubMed ID: 16423283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ndel1 alters its conformation by sequestering cAMP-specific phosphodiesterase-4D3 (PDE4D3) in a manner that is dynamically regulated through Protein Kinase A (PKA).
    Collins DM; Murdoch H; Dunlop AJ; Charych E; Baillie GS; Wang Q; Herberg FW; Brandon N; Prinz A; Houslay MD
    Cell Signal; 2008 Dec; 20(12):2356-69. PubMed ID: 18845247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonredundant function of phosphodiesterases 4D and 4B in neutrophil recruitment to the site of inflammation.
    Ariga M; Neitzert B; Nakae S; Mottin G; Bertrand C; Pruniaux MP; Jin SL; Conti M
    J Immunol; 2004 Dec; 173(12):7531-8. PubMed ID: 15585880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of mRNA encoding cAMP-specific phosphodiesterase isoforms in rat parotid glands.
    Imai A; Nashida T; Shimomura H
    Biochem Mol Biol Int; 1996 Dec; 40(6):1175-81. PubMed ID: 8988329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipopolysaccharide administration in vivo induces differential expression of cAMP-specific phosphodiesterase 4B mRNA splice variants in the mouse brain.
    Johansson EM; Sanabra C; Cortés R; Vilaró MT; Mengod G
    J Neurosci Res; 2011 Nov; 89(11):1761-72. PubMed ID: 21748778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of human inflammatory cell function by subtype-selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4B.
    Manning CD; Burman M; Christensen SB; Cieslinski LB; Essayan DM; Grous M; Torphy TJ; Barnette MS
    Br J Pharmacol; 1999 Dec; 128(7):1393-8. PubMed ID: 10602317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphodiesterase 4 and its inhibitors in inflammatory diseases.
    Jin SL; Ding SL; Lin SC
    Chang Gung Med J; 2012; 35(3):197-210. PubMed ID: 22735051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective SUMO modification of cAMP-specific phosphodiesterase-4D5 (PDE4D5) regulates the functional consequences of phosphorylation by PKA and ERK.
    Li X; Vadrevu S; Dunlop A; Day J; Advant N; Troeger J; Klussmann E; Jaffrey E; Hay RT; Adams DR; Houslay MD; Baillie GS
    Biochem J; 2010 Apr; 428(1):55-65. PubMed ID: 20196770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PDE4D phosphorylation: A coincidence detector integrating multiple signaling pathways.
    Mika D; Conti M
    Cell Signal; 2016 Jul; 28(7):719-24. PubMed ID: 26562185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FSH-induced phosphoprotein phosphatase 2A-mediated deactivation of particulate phosphodiesterase-4 activities is abolished after alteration in proteoglycan synthesis in immature rat Sertoli cells.
    Levallet G; Levallet J; Bonnamy PJ
    J Endocrinol; 2008 Apr; 197(1):45-54. PubMed ID: 18372231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential type 4 cAMP-specific phosphodiesterase (PDE4) expression and functional sensitivity to PDE4 inhibitors among rats, monkeys and humans.
    Bian H; Zhang J; Wu P; Varty LA; Jia Y; Mayhood T; Hey JA; Wang P
    Biochem Pharmacol; 2004 Dec; 68(11):2229-36. PubMed ID: 15498513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential distribution of PDE4D splice variant mRNAs in rat brain suggests association with specific pathways and presynaptical localization.
    Miró X; Pérez-Torres S; Puigdomènech P; Palacios JM; Mengod G
    Synapse; 2002 Sep; 45(4):259-69. PubMed ID: 12125047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expression and function of phosphodiesterase 4 (PDE4) subtypes in human primary CD4+ T cells: predominant role of PDE4D.
    Peter D; Jin SL; Conti M; Hatzelmann A; Zitt C
    J Immunol; 2007 Apr; 178(8):4820-31. PubMed ID: 17404263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of cAMP-specific phosphodiesterase mRNAs distribution in mouse and rat brain.
    Johansson EM; Reyes-Irisarri E; Mengod G
    Neurosci Lett; 2012 Sep; 525(1):1-6. PubMed ID: 22884617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dexamethasone down-regulates cAMP-phosphodiesterase in human osteosarcoma cells.
    Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
    Biochem Pharmacol; 2005 Jan; 69(2):267-75. PubMed ID: 15627479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of pregnancy on PDE4 cAMP-specific phosphodiesterase messenger ribonucleic acid expression in human myometrium.
    Leroy MJ; Méhats C; Duc-Goiran P; Tanguy G; Robert B; Dallot E; Mignot TM; Grangé G; Ferré F
    Cell Signal; 1999 Jan; 11(1):31-7. PubMed ID: 10206342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding PDE4's function in Alzheimer's disease; a target for novel therapeutic approaches.
    Tibbo AJ; Tejeda GS; Baillie GS
    Biochem Soc Trans; 2019 Oct; 47(5):1557-1565. PubMed ID: 31642904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphodiesterase 4 in inflammatory diseases: Effects of apremilast in psoriatic blood and in dermal myofibroblasts through the PDE4/CD271 complex.
    Schafer PH; Truzzi F; Parton A; Wu L; Kosek J; Zhang LH; Horan G; Saltari A; Quadri M; Lotti R; Marconi A; Pincelli C
    Cell Signal; 2016 Jul; 28(7):753-63. PubMed ID: 26806620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.